BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32294643)

  • 1. Double Filtration Plasmapheresis in the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Dysfunction.
    Cheng L; Tang YQ; Yi J; Ren Q; Yang XY; Gou SJ; Zhang L; Fu P
    Blood Purif; 2020; 49(6):713-722. PubMed ID: 32294643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double Filtration Plasmapheresis in the Treatment of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis With Severe Renal Failure: A Preliminary Study of 15 Patients.
    Chen Y; Yang L; Li K; Liu Z; Gong D; Zhang H; Liu Z; Hu W
    Ther Apher Dial; 2016 Apr; 20(2):183-8. PubMed ID: 26948291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.
    Gregersen JW; Kristensen T; Krag SR; Birn H; Ivarsen P
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S39-47. PubMed ID: 22510451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange as an adjunctive therapy in anti-neutrophil cytoplasm antibody-associated vasculitis.
    Gulati K; Pusey CD
    Expert Rev Clin Immunol; 2023 Apr; 19(4):417-430. PubMed ID: 36860127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal vasculitis presenting with acute kidney injury.
    Villacorta J; Diaz-Crespo F; Acevedo M; Cavero T; Guerrero C; Praga M; Fernandez-Juarez G
    Rheumatol Int; 2017 Jun; 37(6):1035-1041. PubMed ID: 28289874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study.
    Liu X; Xia M; Liu D; Liu H; Tang C; Chen G; Liu Y; Yuan F; Liu H
    Ann Med; 2023 Dec; 55(1):2230875. PubMed ID: 37452682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
    Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
    J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
    Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
    Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
    Gong D; Ji D; Xu B; Liu Z
    Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Plasma Exchange in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Nishimura K; Waki D; Kadoba K; Mukoyama H; Yokota T; Murabe H
    Ther Apher Dial; 2019 Jun; 23(3):248-252. PubMed ID: 31033197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late effects of therapeutic plasma exchange in patients with systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis: A single-center experience.
    Al Hamzi HA; Al-Mayouf SM; Al Shaikh AA; Al-Sheikh HA; Alshomar AA; Al Humaidan HA; Al Dalaan AN; Al Saleh SS
    Saudi J Kidney Dis Transpl; 2019; 30(4):775-780. PubMed ID: 31464233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement.
    Chu X; Hong Y; Wang Y; Yu C; Wang L; Tong H; Yan J; Zhang Z; Xu G; Yao Y; Zeng R
    Am J Nephrol; 2021; 52(12):899-908. PubMed ID: 34875652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double filtration plasmapheresis for children with different types of critical kidney diseases: a single-center retrospective cohort study.
    Zhang Y; Xie Q; Chen Y; Yang J; Huang S; Deng L; Zhou J
    Transl Pediatr; 2023 Mar; 12(3):354-363. PubMed ID: 37035407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome.
    Huang X; Chen L; Lan L; Ren P; Ni A; Ma Y; Wang Y; Zhu Y; Xu Y; Chen J; Han F
    Front Immunol; 2021; 12():641655. PubMed ID: 34305886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    Walsh M; Merkel PA; Peh CA; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW;
    N Engl J Med; 2020 Feb; 382(7):622-631. PubMed ID: 32053298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange for the management of ANCA-associated vasculitis: the con position.
    Specks U; Fussner LA; Cartin-Ceba R; Casal Moura M; Zand L; Fervenza FC
    Nephrol Dial Transplant; 2021 Jan; 36(2):231-236. PubMed ID: 33374017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
    Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
    J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.
    de Joode AA; Sanders JS; Smid WM; Stegeman CA
    J Clin Apher; 2014 Oct; 29(5):266-72. PubMed ID: 24497412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
    Vatazin AV; Zulkarnaev AB
    Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.